Ignite Creation Date:
2025-12-25 @ 3:46 AM
Ignite Modification Date:
2026-01-09 @ 11:28 PM
Study NCT ID:
NCT07006402
Status:
RECRUITING
Last Update Posted:
2025-06-05
First Post:
2025-05-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Effects of Reverse Natural Apophyseal Glides as Compared to Ventro-cranial Translatoric Glides in the Management of Upper Thoracic Spine Hypomobility.
Sponsor:
Foundation University Islamabad
Organization:
Study Overview
Official Title:
Effects of Reverse Natural Apophyseal Glides as Compared to Ventro-cranial Translatoric Glides in the Management of Upper Thoracic Spine Hypomobility.
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is a randomized controlled trial and the purpose of the study is to determine the effects of reverse NAGs as compared to Ventro-cranial Translatoric Glides in upper thoracic spine hypomobility in terms of pain and range of motion.
Detailed Description:
OBJECTIVES:
The objectives of this study are :
1. To determine the effects of reverse NAGs as compared to ventrocranial translatoric glide on UPPER BACK PAIN in upper thoracic spine hypomobility.
2. To determine the effects of reverse NAGs as compared to ventrocranial translatoric glide on THORACIC ROM in upper thoracic spine hypomobility.
HYPOTHESIS:
Alternate Hypothesis:
1. There will be a statistically significant difference in the effects of reverse NAGs as compared to ventrocranial translatoric glides in terms of upper back pain in persons with upper thoracic hypo mobility (p\<0.05).
2. There will be a statistically significant difference in the effects of reverse NAGs as compared to ventrocranial translatoric glides in terms of thoracic ROM in persons with upper thoracic hypo mobility (p\<0.05).
NULL HYPOTHSIS :
1. There will be no statistically significant difference in the effects of reverse NAGs as compared to ventrocranial translatoric glides in terms of upper back pain in persons with upper thoracic hypo mobility (p\>0.05).
2. There will be no statistically significant difference in the effects of reverse NAGs as compared to ventrocranial translatoric glides in terms of thoracic ROM in persons with upper thoracic hypo mobility (p\>0.05).
RESEARCH DESIGN : Experimental study .Randomized control trail.
The objectives of this study are :
1. To determine the effects of reverse NAGs as compared to ventrocranial translatoric glide on UPPER BACK PAIN in upper thoracic spine hypomobility.
2. To determine the effects of reverse NAGs as compared to ventrocranial translatoric glide on THORACIC ROM in upper thoracic spine hypomobility.
HYPOTHESIS:
Alternate Hypothesis:
1. There will be a statistically significant difference in the effects of reverse NAGs as compared to ventrocranial translatoric glides in terms of upper back pain in persons with upper thoracic hypo mobility (p\<0.05).
2. There will be a statistically significant difference in the effects of reverse NAGs as compared to ventrocranial translatoric glides in terms of thoracic ROM in persons with upper thoracic hypo mobility (p\<0.05).
NULL HYPOTHSIS :
1. There will be no statistically significant difference in the effects of reverse NAGs as compared to ventrocranial translatoric glides in terms of upper back pain in persons with upper thoracic hypo mobility (p\>0.05).
2. There will be no statistically significant difference in the effects of reverse NAGs as compared to ventrocranial translatoric glides in terms of thoracic ROM in persons with upper thoracic hypo mobility (p\>0.05).
RESEARCH DESIGN : Experimental study .Randomized control trail.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: